Lisata Therapeutics logo

Lisata Therapeutics

LSTA | NASDAQ
Chart Builder DCF Calculator
$1.09
-$0.12 (-9.92%)
At close: Nov 16, 2026, 4:00 PM ET
$1.10
+$0.01 (+0.94%)
After-hours: Nov 16, 2026, 5:56 PM ET
-9.92%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
43.2
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #438/1021 (Top 43%)

Key Statistics

Market Data

Market Cap $9.82M
1D Range
1.04 1.22
52W Range
0.99 5.04

Valuation (TTM)

PE -0.58
PB 1.29
EV/EBITDA N/A

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $0.00
Loading financial charts...

Profile

Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progressio...

Sector Healthcare
Industry Biotechnology
Employees 21
IPO Date Mar 1, 1999
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Hold
Buy (0)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.